Neuberger Berman Group LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 126 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2017. The put-call ratio across all filers is 1.51 and the average weighting 0.6%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q2 2024$5,795,223
+19.1%
53,769
+4.8%
0.01%
+25.0%
Q1 2024$4,867,077
+24.1%
51,308
+20.7%
0.00%
+33.3%
Q4 2023$3,920,754
+37.5%
42,506
-25.1%
0.00%0.0%
Q3 2023$2,850,838
-20.0%
56,767
+0.6%
0.00%0.0%
Q2 2023$3,564,543
+83.5%
56,401
+30.6%
0.00%
+50.0%
Q1 2023$1,942,488
+12.4%
43,176
+9.5%
0.00%0.0%
Q4 2022$1,727,866
-6.2%
39,440
+41.0%
0.00%0.0%
Q3 2022$1,842,000
+130.0%
27,963
+179.6%
0.00%
+100.0%
Q4 2019$801,000
-51.5%
10,000
-55.6%
0.00%
-50.0%
Q3 2019$1,653,000
-38.7%
22,500
-21.3%
0.00%
-33.3%
Q2 2019$2,698,000
+68.5%
28,600
+43.0%
0.00%
+50.0%
Q1 2019$1,601,000
+79.9%
20,000
+106.0%
0.00%
+100.0%
Q1 2018$890,000
+18.0%
9,711
-2.9%
0.00%0.0%
Q4 2017$754,000
+14.4%
10,000
-39.3%
0.00%0.0%
Q1 2017$659,000
+121.1%
16,479
+55.2%
0.00%
Q4 2016$298,00010,6180.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2017
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 559,381$41,098,00015.69%
Casdin Capital, LLC 940,000$69,061,800,0007.15%
Ghost Tree Capital, LLC 325,000$23,878,0006.08%
CADIAN CAPITAL MANAGEMENT, LP 1,418,704$104,232,0004.96%
DAFNA Capital Management LLC 123,218$9,053,0003.40%
BVF INC/IL 437,565$32,148,0003.38%
Opaleye Management Inc. 105,000$7,714,0002.79%
Cormorant Asset Management, LP 493,000$36,221,0002.20%
Novo Holdings A/S 170,667$12,539,0002.15%
Artal Group S.A. 600,000$44,082,0001.77%
View complete list of BLUEPRINT MEDICINES CORP shareholders